Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 416-424, August 2010

Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma

  • Manuela Schmidinger

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology and Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 40400 4429; fax: +43 1 40400 4498.
    • ,
  • Joaquim Bellmunt

      Affiliations

    • Solid Tumor Oncology (Genitourinary and Gastrointestinal), Medical Oncology Service, Hospital Del Mar, Paseo Maritimo 25–29, Barcelona 08003, Spain

Received 23 October 2009; received in revised form 13 January 2010; accepted 18 January 2010. published online 17 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00018-6

doi:10.1016/j.ctrv.2010.01.003

Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 416-424, August 2010

Article Tools